Risk of Invokana Side Effects May Outweigh Benefits: Report
A new report raises questions as to whether the health risks linked to the new diabetes drug Invokana outweigh its benefits.
A new report raises questions as to whether the health risks linked to the new diabetes drug Invokana outweigh its benefits.
Johnson & Johnson has high hopes that its recently approved diabetes drug, Invokana, will break the trend of problems that have surfaced in recent years with many newer diabetes medications,…